Biomarker Candidates for Alzheimer’s Disease Unraveled through In Silico Differential Gene Expression Analysis

Alzheimer’s disease (AD) is neurodegeneration that accounts for 60–70% of dementia cases. Symptoms begin with mild memory difficulties and evolve towards cognitive impairment. The underlying risk factors remain primarily unclear for this heterogeneous disorder. Bioinformatics is a relevant research...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva-Lucero, Maria-del-Carmen, Rivera-Osorio, Jared, Gómez-Virgilio, Laura, Lopez-Toledo, Gustavo, Luna-Muñoz, José, Montiel-Sosa, Francisco, Soto-Rojas, Luis O., Pacheco-Herrero, Mar, Cardenas-Aguayo, Maria-del-Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139748/
https://www.ncbi.nlm.nih.gov/pubmed/35626321
http://dx.doi.org/10.3390/diagnostics12051165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139748/
https://www.ncbi.nlm.nih.gov/pubmed/35626321
http://dx.doi.org/10.3390/diagnostics12051165

Ejemplares similares